No­vo Nordisk’s trou­bled fac­to­ry in In­di­ana that it got from Catal­ent con­tin­ues to face con­t­a­m­i­na­tion is­sues, with a re-in­spec­tion in April find­ing mam­malian hair in...

Back­lash is brew­ing against a sweep­ing over­haul of Ger­many’s health in­sur­ance sys­tem as Eli Lil­ly and Boehringer In­gel­heim slash in­vest­ment in the coun­try.

The drug­mak­er­s'...

Plus, news about West Phar­ma­ceu­ti­cal, Stal­ler­genes Greer and Curi­um:

🏭 Hik­ma’s US ex­pan­sion: The gener­ic drug­mak­er is in­vest­ing$267 mil­lion in Ohio. Its ex­ist­ing fac­to­ry...

A bi­par­ti­san group of Michi­gan law­mak­ers re­leased a new bill that could great­ly sti­fle the boom­ing cross-bor­der deals spree be­tween Chi­nese and Amer­i­can biotechs.

Rep...

The Supreme Court has unan­i­mous­ly sided with Hik­ma Phar­ma­ceu­ti­cals and its “skin­ny la­bel” ver­sion of a pre­scrip­tion-strength fish oil pill in a case that was...

Eli Lil­ly is giv­ing a group of hos­pi­tals five days to com­ply with its new claims da­ta pol­i­cy or risk los­ing their 340B dis­counts.

Some...